About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Study Of RV-39 In Patients Who Also Have Asthma

NCT00503009·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

GlaxoSmithKline

Age

18–40

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Have asthma for at least 3 months prior to the study.
Have been using an allowed pre-study asthma therapy for at least 3 months prior to study.
Demonstrate airway hyperresponsiveness following inhalation of bronchoconstrictor.
Have a positive allergic status antibody test.

You may not be if

Have a history of life-threatening asthma.
Been hospitalized for asthma within the 24 months prior to the study.
Have certain conditions that would make study participation unsafe.

The record

StatusTerminated

PhasePhase 4

Taking part16

StartedOct 2007

UpdatedDec 28, 2016

Conditions

Where1

GSK Investigational Site
Charlottesville, Virginia, United States

Clareo Health | Study Of RV-39 In Patients Who Also Have Asthma